JPWO2021187548A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021187548A5 JPWO2021187548A5 JP2022508425A JP2022508425A JPWO2021187548A5 JP WO2021187548 A5 JPWO2021187548 A5 JP WO2021187548A5 JP 2022508425 A JP2022508425 A JP 2022508425A JP 2022508425 A JP2022508425 A JP 2022508425A JP WO2021187548 A5 JPWO2021187548 A5 JP WO2021187548A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- alkyl
- pharmaceutically acceptable
- acceptable salt
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026003199A JP2026050471A (ja) | 2020-03-19 | 2026-01-13 | 慢性心不全の治療又は予防方法 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020048798 | 2020-03-19 | ||
| PCT/JP2021/011003 WO2021187548A1 (ja) | 2020-03-19 | 2021-03-18 | 慢性心不全の治療又は予防方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026003199A Division JP2026050471A (ja) | 2020-03-19 | 2026-01-13 | 慢性心不全の治療又は予防方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2021187548A1 JPWO2021187548A1 (https=) | 2021-09-23 |
| JPWO2021187548A5 true JPWO2021187548A5 (https=) | 2024-03-27 |
Family
ID=77770987
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022508425A Pending JPWO2021187548A1 (https=) | 2020-03-19 | 2021-03-18 | |
| JP2026003199A Pending JP2026050471A (ja) | 2020-03-19 | 2026-01-13 | 慢性心不全の治療又は予防方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026003199A Pending JP2026050471A (ja) | 2020-03-19 | 2026-01-13 | 慢性心不全の治療又は予防方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230321044A1 (https=) |
| EP (1) | EP4122495A4 (https=) |
| JP (2) | JPWO2021187548A1 (https=) |
| KR (1) | KR20220156574A (https=) |
| CN (1) | CN115209919B (https=) |
| AU (1) | AU2021237149A1 (https=) |
| BR (1) | BR112022018396A2 (https=) |
| CA (1) | CA3175131A1 (https=) |
| MX (1) | MX2022011490A (https=) |
| WO (1) | WO2021187548A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020343585B2 (en) * | 2019-09-04 | 2026-02-05 | Shionogi & Co., Ltd. | Chronic kidney disease treatment or prevention method |
| MX2022002683A (es) * | 2019-09-04 | 2022-04-07 | Japan Tobacco Inc | Metodo terapeutico o profilactico para diabetes usando medicamentos combinados. |
| WO2023210634A1 (ja) * | 2022-04-28 | 2023-11-02 | 国立大学法人東海国立大学機構 | 拡張障害を伴う心不全の治療用医薬組成物 |
| WO2025249555A1 (en) * | 2024-05-31 | 2025-12-04 | Japan Tobacco Inc. | Method for treating or preventing hypertrophic cardiomyopathy |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200735880A (en) * | 2006-01-27 | 2007-10-01 | Sankyo Co | Medicinal compositions for preventing or treating heart failure |
| AR087701A1 (es) * | 2011-08-31 | 2014-04-09 | Japan Tobacco Inc | Derivados de pirazol con actividad inhibidora de sglt1 |
| CN110066302B (zh) * | 2018-01-23 | 2022-12-27 | 广东东阳光药业有限公司 | 吡喃葡萄糖基衍生物及其用途 |
| TWI805699B (zh) * | 2018-03-01 | 2023-06-21 | 日商日本煙草產業股份有限公司 | 甲基內醯胺環化合物及其用途 |
| MX2020010433A (es) * | 2018-04-04 | 2020-10-28 | Japan Tobacco Inc | Compuestos de pirazol sustituidos con heteroarilo y uso farmaceutico de los mismos. |
| MX2022002683A (es) * | 2019-09-04 | 2022-04-07 | Japan Tobacco Inc | Metodo terapeutico o profilactico para diabetes usando medicamentos combinados. |
-
2021
- 2021-03-18 EP EP21772065.5A patent/EP4122495A4/en active Pending
- 2021-03-18 JP JP2022508425A patent/JPWO2021187548A1/ja active Pending
- 2021-03-18 WO PCT/JP2021/011003 patent/WO2021187548A1/ja not_active Ceased
- 2021-03-18 MX MX2022011490A patent/MX2022011490A/es unknown
- 2021-03-18 BR BR112022018396A patent/BR112022018396A2/pt not_active Application Discontinuation
- 2021-03-18 CA CA3175131A patent/CA3175131A1/en active Pending
- 2021-03-18 AU AU2021237149A patent/AU2021237149A1/en active Pending
- 2021-03-18 US US17/796,606 patent/US20230321044A1/en active Pending
- 2021-03-18 KR KR1020227035794A patent/KR20220156574A/ko active Pending
- 2021-03-18 CN CN202180021810.3A patent/CN115209919B/zh active Active
-
2026
- 2026-01-13 JP JP2026003199A patent/JP2026050471A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2021187548A5 (https=) | ||
| CN114072396A (zh) | 作为dna-pk抑制剂的喹啉和噌啉衍生物 | |
| JP2014502641A5 (https=) | ||
| JP2019094345A5 (https=) | ||
| JP2018534288A5 (https=) | ||
| JP2019517487A5 (https=) | ||
| JP2016530259A5 (https=) | ||
| JP2017528507A5 (https=) | ||
| JP2015508103A5 (https=) | ||
| JP2017504611A5 (https=) | ||
| JP2019505529A5 (https=) | ||
| JP2019517587A5 (https=) | ||
| JP2010527985A5 (https=) | ||
| JP2016510785A5 (https=) | ||
| JP2009513713A5 (https=) | ||
| JPWO2020163823A5 (https=) | ||
| EP2455080A1 (en) | S1P1 receptor agonists for use in the treatment of multiple sclerosis | |
| JP2015503596A5 (https=) | ||
| CN115315423A (zh) | 取代芳基类化合物 | |
| JP2017524013A5 (https=) | ||
| JP2021535147A5 (https=) | ||
| JP2019508476A5 (https=) | ||
| JP2009541387A5 (https=) | ||
| JP2009511450A5 (https=) | ||
| JPWO2020175629A5 (https=) |